This is a clear indication of the involvement of aberrant IL-7–IL-7R signaling in human CD8αβ+ γδ T-ALL, given that high levels of IL7R in patients with T-ALL are known to associate with oncogenic IL-7R-dependent signaling activation35. The gene discussed is IL7R; the disease is acute lymphoblastic leukemia.